Diagnostic and prognostic implications of non-high-density lipoprotein cholesterol and homocysteine levels for cognitive impairment in thalamic infarction

Table 6 Differences in clinical characteristics between patients with thalamic infarction in the good and poor prognosis groups

Project	Good prognosis group (n = 50)	Poor prognosis group (n = 30)	χ2/t	P value
Age (yr)	65.12 ± 6.74	64.13 ± 10.07	0.527	0.600
Men	32 (64.00)	20 (66.67)	0.059	0.809
Time of onset (h)	20.39 ± 3.21	20.42 ± 3.19	0.041	0.968
Smoking history	26 (52.00)	16 (53.33)	0.013	0.908
The history of drinking	24 (48.00)	13 (43.33)	0.164	0.685
Hypertension	24 (48.00)	18 (60.00)	1.083	0.298
Diabetes	14 (28.00)	9 (30.00)	0.037	0.848
CHD	8 (16.00)	4 (13.33)	0.105	0.746
NIHSS score	14.52 ± 5.43	17.91 ± 5.78	2.639	0.010
Non-HDL-C (tendency/L)	3.08 ± 0.46	3.79 ± 0.57	6.103	0.000
Hcy (μmol/L)	14.54 ± 0.78	27.51 ± 4.08	21.909	0.000
Massive cerebral infarction	13 (26.00)	15 (50.00)	4.747	0.029
Atrial fibrillation	6 (12.00)	9 (30.00)	3.988	0.046
APTT (1 S)	31.55 ± 3.45	33.43 ± 4.32	2.144	0.035

APTT: Activated partial prothrombin time; CHD: Coronary heart disease; Non-HDL-C: Non-high-density lipoprotein cholesterol; Hcy: Homocysteine; NIHSS: National Institutes of Health Stroke Scale.